文献速递艾滋病与性传播感染

利用分子与培养方法评估男男性行为者沙眼衣原体的存活性

Viability assessment of Chlamydia trachomatis in men who have sex with men using molecular and culture methods.
PubMed 文献 · Clin Microbiol Infect · 2025-01-08

研究建立并验证基于PCR的沙眼衣原体(CT)存活性检测(V-PCR),并应用于男男性行为者(MSM)直肠肛拭子。236份拭子中69份(29.2%)CT PCR阳性,54份获得V-PCR数据;细胞培养成功分离39/69份(56.5%),ompA基因分型获得62/69份(89.9%)。作者认为该检测可区分、检测并定量存活CT,可能有助于改善抗菌药物管理。

要点

  • 54份V-PCR样本中27份(50.0%)存活CT比例为50.01%至100%。
  • 69份CT PCR阳性肛拭子中细胞培养成功分离39份(56.5%)。
  • ompA分型以G、D/Da、J型各15/62份居多,E型11/62份。

核心结论

  • 作者成功实施基于PCR的存活性检测,可在MSM直肠肛拭子中区分、检测并定量存活CT。
  • 作者认为快速可靠的CT存活性评估可能有助于改善抗菌药物管理。

研究设计与样本

  • 研究先以已知存活与非存活CT比例的人工样本验证已发表的V-PCR方案,样本经propidium monoazide(PMAxx)处理后再行DNA提取与定量PCR(qPCR)。
  • 随后将V-PCR应用于MSM的CT PCR阳性直肠肛拭子,并行细胞培养分离及ompA基因测序分型。
  • 共检测236份直肠肛拭子,其中69份(29.2%)CT PCR阳性,54份获得V-PCR数据。

主要发现

  • V-PCR结果:54份中7份(12.9%)存活CT<1%(>2.52 ΔLog10 CT/mL),4份(7.4%)存活CT 1%至10%(1.59-2.52),16份(29.6%)存活CT 10.01%至50%(0.86-1.59),27份(50.0%)存活CT 50.01%至100%(<0.35-0.86)。
  • 细胞培养从69份中成功分离CT 39份(56.5%)。
  • ompA分型获得62/69份(89.9%):G型15/62份、D/Da型15/62份、J型15/62份、E型11/62份、L1型4/62份、L2型2/62份。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Chlamydia trachomatis (CT) is the most commonly reported bacterial sexually transmitted infection worldwide. Diagnosis relies on nucleic acid amplification techniques, such as PCR, which does not distinguish between viable pathogens and residual bacterial DNA, leading to potential overdiagnosis and overtreatment. PCR with confirmation of pathogen viability has not been widely explored in the sexually transmitted infection field. We aimed to establish a CT viability PCR (V-PCR) and to apply it to anorectal swabs from men who have sex with men (MSM). METHODS: We validated a published V-PCR protocol by preparing artificial samples with known ratios of viable and non-viable CT. Mock samples were treated with propidium monoazide (PMAxx) before DNA extraction and quantitative PCR (qPCR) to detect CT. The V-PCR was then applied to CT PCR-positive anorectal swabs from MSM. Viability was expressed as the difference in CT copies between PMAxx untreated and treated samples (ΔLog10 CT/mL). The anorectal samples were inoculated in cell culture for isolation. Genotyping was performed by examining the ompA gene sequence. RESULTS: Of 236 anorectal swabs, 69 (29.2%) were CT PCR positive, and we obtained V-PCR data from 54. There were 7 of 54 (12.9%), samples with <1% viable CT (>2.52 ΔLog10 CT/mL) 4 of 54 (7.4%) samples with 1% to 10% viable CT (1.59-2.52), 16 of 54 (29.6%) with 10.01% to 50% viable CT (0.86-1.59) and 27 of 54 (50.0%) with 50.01% to 100% viable CT (<0.35-0.86). CT was isolated successfully from 39 of 69 (56.5%) samples in cell culture. Genotypes based on ompA were obtained for 62 of 69 (89.9%) samples: G (n = 15/62), D/Da (n = 15/62), J (n = 15/62), E (n = 11/62), L1 (n = 4/62), and L2 (n = 2). DISCUSSION: We successfully implemented a viability test based on PCR, which can distinguish, detect and quantify viable CT in anorectal swabs from MSM. Rapid, reliable assessment of CT viability could help to improve antimicrobial stewardship.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Rayo E, Pesch T, Onorini D, et al. Viability assessment of Chlamydia trachomatis in men who have sex with men using molecular and culture methods. Clin Microbiol Infect. 2025. PMID: 39793963. doi:10.1016/j.cmi.2024.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。